Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 6
2015 4
2016 8
2017 3
2018 3
2019 3
2020 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Targeted deletion of PD-1 in myeloid cells induces antitumor immunity.
Strauss L, Mahmoud MAA, Weaver JD, Tijaro-Ovalle NM, Christofides A, Wang Q, Pal R, Yuan M, Asara J, Patsoukis N, Boussiotis VA. Strauss L, et al. Sci Immunol. 2020 Jan 3;5(43):eaay1863. doi: 10.1126/sciimmunol.aay1863. Sci Immunol. 2020. PMID: 31901074 Free PMC article.
Immunotherapies for malignant glioma.
Boussiotis VA, Charest A. Boussiotis VA, et al. Oncogene. 2018 Mar;37(9):1121-1141. doi: 10.1038/s41388-017-0024-z. Epub 2017 Dec 15. Oncogene. 2018. PMID: 29242608 Free PMC article. Review.
Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy.
Le Bourgeois T, Strauss L, Aksoylar HI, Daneshmandi S, Seth P, Patsoukis N, Boussiotis VA. Le Bourgeois T, et al. Front Oncol. 2018 Aug 3;8:237. doi: 10.3389/fonc.2018.00237. eCollection 2018. Front Oncol. 2018. PMID: 30123774 Free PMC article. Review.
Clinical significance of T cell metabolic reprogramming in cancer.
Herbel C, Patsoukis N, Bardhan K, Seth P, Weaver JD, Boussiotis VA. Herbel C, et al. Clin Transl Med. 2016 Dec;5(1):29. doi: 10.1186/s40169-016-0110-9. Epub 2016 Aug 10. Clin Transl Med. 2016. PMID: 27510264 Free PMC article. Review.
28 results